Duration of antiviral immunity after smallpox vaccination. 2003

Erika Hammarlund, and Matthew W Lewis, and Scott G Hansen, and Lisa I Strelow, and Jay A Nelson, and Gary J Sexton, and Jon M Hanifin, and Mark K Slifka
Oregon Health & Science University Vaccine and Gene Therapy Institute, 505 NW 185th Avenue, Beaverton, Oregon 97006, USA.

Although naturally occurring smallpox was eliminated through the efforts of the World Health Organization Global Eradication Program, it remains possible that smallpox could be intentionally released. Here we examine the magnitude and duration of antiviral immunity induced by one or more smallpox vaccinations. We found that more than 90% of volunteers vaccinated 25-75 years ago still maintain substantial humoral or cellular immunity (or both) against vaccinia, the virus used to vaccinate against smallpox. Antiviral antibody responses remained stable between 1-75 years after vaccination, whereas antiviral T-cell responses declined slowly, with a half-life of 8-15 years. If these levels of immunity are considered to be at least partially protective, then the morbidity and mortality associated with an intentional smallpox outbreak would be substantially reduced because of pre-existing immunity in a large number of previously vaccinated individuals.

UI MeSH Term Description Entries
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Erika Hammarlund, and Matthew W Lewis, and Scott G Hansen, and Lisa I Strelow, and Jay A Nelson, and Gary J Sexton, and Jon M Hanifin, and Mark K Slifka
June 1953, Sicilia sanitaria,
Erika Hammarlund, and Matthew W Lewis, and Scott G Hansen, and Lisa I Strelow, and Jay A Nelson, and Gary J Sexton, and Jon M Hanifin, and Mark K Slifka
August 2002, Japanese journal of infectious diseases,
Erika Hammarlund, and Matthew W Lewis, and Scott G Hansen, and Lisa I Strelow, and Jay A Nelson, and Gary J Sexton, and Jon M Hanifin, and Mark K Slifka
September 1898, The Southern medical record,
Erika Hammarlund, and Matthew W Lewis, and Scott G Hansen, and Lisa I Strelow, and Jay A Nelson, and Gary J Sexton, and Jon M Hanifin, and Mark K Slifka
January 1973, Trudy Leningradskogo nauchno-issledovatel'skogo instituta epidemiologii i mikrobiologii imeni Pastera,
Erika Hammarlund, and Matthew W Lewis, and Scott G Hansen, and Lisa I Strelow, and Jay A Nelson, and Gary J Sexton, and Jon M Hanifin, and Mark K Slifka
March 1935, The Indian medical gazette,
Erika Hammarlund, and Matthew W Lewis, and Scott G Hansen, and Lisa I Strelow, and Jay A Nelson, and Gary J Sexton, and Jon M Hanifin, and Mark K Slifka
January 1952, Social-Medicinsk tidskrift,
Erika Hammarlund, and Matthew W Lewis, and Scott G Hansen, and Lisa I Strelow, and Jay A Nelson, and Gary J Sexton, and Jon M Hanifin, and Mark K Slifka
September 1973, Lancet (London, England),
Erika Hammarlund, and Matthew W Lewis, and Scott G Hansen, and Lisa I Strelow, and Jay A Nelson, and Gary J Sexton, and Jon M Hanifin, and Mark K Slifka
January 1954, Annales de la Societe belge de medecine tropicale (1920),
Erika Hammarlund, and Matthew W Lewis, and Scott G Hansen, and Lisa I Strelow, and Jay A Nelson, and Gary J Sexton, and Jon M Hanifin, and Mark K Slifka
May 1952, Svenska lakartidningen,
Erika Hammarlund, and Matthew W Lewis, and Scott G Hansen, and Lisa I Strelow, and Jay A Nelson, and Gary J Sexton, and Jon M Hanifin, and Mark K Slifka
October 1973, Lancet (London, England),
Copied contents to your clipboard!